|
|
|
Cholinesterase
Cholinesterase: - An enzyme found in animals that regulates nerve impulses by the inhibition of acetylcholine. Cholinesterase inhibition is associated with a variety of acute symptoms such as nausea, vomiting, blurred vision, stomach cramps, and rapid heart rate. [Environmental Protection Agency] News archive for Cholinesterase:: |
MarketWatchA randomized, double-blind, placebo-controlled trial of 677 outpatients already taking a cholinesterase inhibitor was conducted in multiple centers in the
Muted placebo declines complicating Alzheimer’s trials - Jul 31, 2008
Pharma Times (subscription),The existing use of cholinesterase inhibitors was not associated with any less cognitive deterioration in the trials reviewed.
Driving Attention Improved With Drugs Used in Alzheimer's Patients ... - Jul 29, 2008
DG News..."Cholinesterase inhibitor-treated drivers with mild Alzheimer's disease demonstrated faster reaction times and greater response accuracy under conditions of
Forest Laboratories Announces Positive Phase III Data Of ... - Jul 30, 2008
RTT News,...extended-release formulation of Namenda to treat moderate to severe Alzheimer's disease already being treated with a cholinesterase inhibitor.
Old Antihistamine Pops Up as Potential Alzheimer's Therapy - Jul 17, 2008
MedPage Today,By contrast, commonly used cholinesterase inhibitors for mild-to-moderate Alzheimer's disease only temporarily stabilize or slow progressive deterioration
Medicines for treating dementia - Jul 22, 2008
Scoop.co.nz (press release),The new generation medicines cholinesterase inhibitors and memantine are publicly funded in other OECD countries, but not in New Zealand.
Priority Toxics Bills Important to the Health of Californians Near ... - Jul 12, 2008
California Progress Report,Assemblymember Lieber's AB 1530 requires any laboratory that performs cholinesterase testing on a specimen of human blood electronically to report
Controversy About Lack of Placebo Group Decline in Alzheimer's ... - Jul 28, 2008
Earthtimes (press release),The relatively common use of the currently approved Alzheimer drugs (cholinesterase inhibitors and memantine) by populations involved in the clinical trials
/CORRECTION -- Medivation, Inc./ - Jul 30, 2008
MarketWatch..."All of the approved Alzheimer's disease drugs operate by one of two mechanisms -- cholinesterase inhibition or NMDA-receptor antagonism," noted Bengt
Forest Laboratories announces positive Phase III data for ... - Aug 1, 2008
Trading Markets (press release),...outpatients with moderate to severe Alzheimer's disease already being treated with a cholinesterase inhibitor (donepezil, galantamine or rivastigmine).
Promising New Drug Development Announced at Alzheimer’s Conference - Jul 31, 2008
HealthNews,The trail results suggest rember is about two-and-a-half times more effective than existing Alzheimer's drugs called cholinesterase inhibitors.
Rember for Alzheimer's: Methylene Blue's Comeback - Jul 31, 2008
Corante,...(this is the best I've seen), was significantly more effective than the current standard of care (Aricept/donezepil, a cholinesterase inhibitor).
No happy endings for Alzheimer's campaigner - Jul 19, 2008
Stuff.co.nz,Some sufferers can't afford the cholinesterase inhibitor drugs for instance, which Pharmac refuses to subsidise "because its benefits are unproven".
Fourth International Consultation On Incontinence (ICI) - Frail ... - Jul 25, 2008
Medical News Today (press release),CNS white matter signal abnormalities (Level 4), depression (Level 3), cholinesterase inhibitors (Level 3), and functional impairments (Level 1).
Understanding Alzheimer’s disease - Jul 23, 2008
Bancroft This Week,A group of medications called cholinesterase inhibitors may help preserve the ability of damaged nerve endings to transmit messages from one nerve cell to
�人癡呆新藥�世減慢惡化速度81％ - Jul 30, 2008
雅虎香港,...ç ”ç©¶è‰æ˜ŽRember有助防æ¢æ–°çš„「糾çµ?ã€?å½¢æˆ?，並紓緩已有的「糾çµ?ã€?情况，比ç?¾æ™‚常用的「乙醯膽鹼抑制劑ã€?（cholinesterase
Antihistaminikum bremst Alzheimer - Jul 25, 2008
Ärzte Zeitung,Z um Vergleich: In Studien mit Cholinesterase-Hemmern betrug die Differenz nach einem halben Jahr im Schnitt etwa drei Punkte. Nach einem weiteren halben
EPA Under Fire for Flawed Pesticide Decisions on Diazinon - Jul 29, 2008
PressZoom (press release),Exposure to diazinon can result a neurological impairment called cholinesterase inhibition. Symptoms include muscle spasms, confusion, dizziness, seizures,
Antidementiva nur für ein Drittel der Demenzkranken - Jul 18, 2008
Ärzte Zeitung,Obwohl ihr Nutzen bei Patienten mit Alzheimer-Demenz unbestritten ist, werden Cholinesterase-Hemmer in der Praxis immer noch zögerlich verordnet.
Demenz: Früher Therapiestart lohnt sich - Jul 7, 2008
Ärzte Zeitung,In vier analysierten Studien erkrankten mit Placebo innerhalb von zwei bis drei Jahren zwar mehr MCI-Patienten an Alzheimer als mit Cholinesterase-Hemmern.
Nuove linee guida sulla demenza - Jul 20, 2008
Pillole.org,Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline.
Bei Demenz-Kranken bleibt Kommunikaton zwischen Arzt und Pflegern ... - Jul 14, 2008
Ärzte Zeitung,Demnach erhält nur ein Drittel der Patienten mit Demenz-Diagnose einen Cholinesterase-Hemmer oder Memantine. 55 Prozent bekommen gar keine antidementive
Medivation’s candidate Dimebon under heavy scrutiny due to lack of ... - 02 Dec 2007
Financial Times,The current most plausible mechanisms of action treating Alzheimer’s are cholinesterase inhibition and NMDA-receptor antagonists, but the company is trying
Drugs May Not Delay Onset Of Dementia - Nov 26, 2007
Science Daily (press release)They have concluded that these drugs (cholinesterase inhibitors) do not seem to delay the appearance of Alzheimer disease or other forms of dementia.
Alzheimer drugs don't delay dementia onset -study - Nov 26, 2007
ReutersSome experts and patient groups have called for such anti-cholinesterase drugs to be given to people with mild cognitive impairment (MCI) -- a condition
Drugs may not delay onset of dementia - Nov 27, 2007
Earthtimes,The study, published in the journal PLoS Med, looked at three cholinesterase inhibitors -- donepezil, rivastigmine and galantamine -- currently approved for
Drug May Restore Memory With Alzheimer's Disease - Nov 13, 2007
NewsMax.com,Cholinesterase inhibitors are approved for mild to moderate Alzheimer’s. The fifth medication, Namenda®, is an antagonist of the N-methyl D-aspartate
Mom's medication taken away WRHA policy discriminatory, brothers claim - Nov 15, 2007
Winnipeg Free Press,Cloutier said that contrary to what the Bars claim, the current policy on cholinesterase inhibitors has been unchanged for several years.
The Pharm Exec Pipeline Report 2007 - Nov 29, 2007
PharmExec.com,Dimebon, a symptomatic agent in the same family as Forest's Namenda (memantine), is a cholinesterase inhibitor and NMDA receptor antagonist that inhibits
Dementia Screening in Primary Care - Nov 27, 2007
Journal of American Medical Association (subscription),5, 4 Some individuals receiving cholinesterase inhibitors (for AD or PDD) or the N-methyl-D-aspartate receptor antagonist memantine (for AD) have improved
Memory Pharmaceuticals Reports Third Quarter 2007 Financial Results - Nov 8, 2007
CNNMoney.comIn the subgroup of subjects receiving cholinesterase inhibitors, the change in ADAS-cog favored treatment over placebo and numeric improvements were seen in
Loss of smell linked to Alzheimer's - Nov 19, 2007
Chicago Flame Online (subscription),Four of the five most common medications used to help treat mild to moderate Alzheimer's disease (AD) are called cholinesterase inhibitors.
Journal of Alzheimer's Disease special issue explores multifaceted ... - Nov 15, 2007
EurekAlert (press release),London (UK) give a brief overview of the clinical effectiveness of cholinesterase inhibitors for the treatment of Alzheimer's disease, discuss in detail
SITUATIONAL SYNCOPE - Nov 13, 2007
EMS Magazine,Acetylcholine agonists permit the buildup of acetylcholine at the receptor site and decrease the ability of cholinesterase to clear the pathway.
Canadian study proves Aricept effective - Jul 30, 2007
Globe and Mail,Donepezil — sold under the brand name Aricept — is one of a class of drugs known as cholinesterase inhibitors, which help restore levels of the
Court says government must review decision to restrict access to ... - Aug 10, 2007
International Herald Tribune,...government's medicines watchdog not to approve a group of drugs known as acetyl cholinesterase inhibitors for patients in early stages of the disease.
Drug Gives New Hope in Treating Symptoms of Severe Alzheimer's - Jul 30, 2007
WM Experts (press release),..."Until now, cholinesterase inhibitor drugs have been used to treat mild to moderate stages of the disease. Now we know they can help preserve cognition and
Aricept Eases Symptoms of Severe Alzheimer's - Jul 30, 2007
HealthCentral.com,Aricept, a cholinesterase inhibitor, was approved a decade ago for mild-to-moderate Alzheimer's dementia. An estimated 21 percent of the 4.5 million
Old Drug May Yield - Aug 7, 2007
Wall Street JournalAlzheimer's patients today are typically put on one of three "cholinesterase inhibitors" - Aricept by Eisai Co. and Pfizer Inc., Exelon by Novartis AG,
Donepezil Effective, Safe in Late-Stage Alzheimer's Disease - Aug 3, 2007
Medscape (subscription)In addition, only patients who had either not received previous AD treatment with cholinesterase inhibitors, memantine, or propentofylline or who had
Alzheimer’s move we could regret - Aug 11, 2007
ic Wales,But the emergence of three “wonder� drugs – acetyl cholinesterase inhibitors called Aricept, Reminyl and Exelon – appears to have altered perceptions and
Campaigners’ anger Alzheimer ruling - Aug 11, 2007
ic Wales,Nice decided that acetyl cholinesterase inhibitors – drugs such as Aricept, Reminyl and Exelon – should not be given to patients with mild Alzheimer’s on
Judge upholds restriction on Alzheimer's drug - Aug 10, 2007
Guardian Unlimited,The organisation decided in November that three acetyl cholinesterase inhibitors - Aricept, Reminyl and Exelon - should only be prescribed to patients in
UK Must Change Alzheimer's Drug Advice - Aug 10, 2007
Washington Post,Clinical Excellence, which declined to approve a group of drugs known as acetyl cholinesterase inhibitors for patients in early stages of the disease.
UPDATE:UK Court Rules Against Detail Of NICE Alzheimer's Policy - Aug 10, 2007
CNNMoney.comThe judge ruled that NICE must therefore review the way it decides which Alzheimer's patients may be prescribed the drugs, known as acetyl cholinesterase
Legal blow for Alzheimer's patients - Aug 10, 2007
Guardian Unlimited,Last year Nice, backed by an appeal panel, decided that three acetyl cholinesterase inhibitors (AChEIs) - Aricept, Reminyl and Exelon - should no longer be
FDA Sends Warning Letter to Novartis Over Professional File Ccard - Aug 15, 2007
PharmaLive.com (press release),The PI also contains precautions for drug-drug interactions (ie, use with anticholingeric and cholinomimetic medications, and other cholinesterase
High Court rules against Alzheimer drugs on NHS - Aug 13, 2007
Legal & Medical Magazine,The judicial review defeated the legal challenge to NICE’s recommendation that cholinesterase inhibitors – Aricept, Reminyl and Exelon – should only be
UK court upholds drug restriction in mild Alzheimer’s - Aug 10, 2007
Peninsula On-line,Anti-cholinesterase drugs such as Aricept can help but not cure some Alzheimer's patients. Other products affected by Nice's decision are Exelon from
Battle for use of Alzheimer’s drugs in those with mild disease lost - Aug 10, 2007
OnMedica,The legal challenge to NICE's recommendation that cholinesterase inhibitors should only be prescribed to people with moderate Alzheimer's disease failed in
Campaigners claim small win in Alzheimer’s drugs battle - Aug 10, 2007
Pharma Times (subscription),NICE first ruled against the use of the acetyl cholinesterase inhibitors Aricept (donepezil), sold by Pfizer and Eisai, Novartis’ Exelon (rivastigmine) and
Aging Baby Boomers and Unmet Medical Needs Drive Alzheimer's and ... - Aug 7, 2007
PR-GB.com (press release),Products segments analyzed include anti-Alzheimer's disease drugs (cholinesterase Inhibitors and NMDARA (N-methyl, D-Aspartate Receptor Antagonists)),
Donepezil Puts the Brakes on Alzheimer's - Jul 31, 2007
Earthtimes.org...“It's now suggesting that cholinesterase inhibitors can be active and can be beneficial in severe-stage disease. It gives physicians, families new options
Medivation drug sets its sights on Huntington's disease - Jul 31, 2007
DrugResearcher.com,It is also believed to block both cholinesterase and the NMDA receptor simultaneously. Of the five existing FDA-approved drugs for Alzheimer's disease,
Drug Improves Some Symptoms in Severe Alzheimer's Disease - Jul 30, 2007
Psychiatric Times,Approved by the FDA in October 2006 to treat severe as well as moderate forms of the disease, the cholinesterase inhibitor proved mildly effective and safe
archives | news | XML / RSS feed | featured
XML / RSS / Syndication options
mongabay.com features more than 350 RSS feeds to meet your specific area of interest
MONGABAY.COM
Mongabay.com seeks to raise interest in and appreciation of wild lands and wildlife, while examining the impact of emerging trends in climate, technology, economics, and finance on conservation and development (more)
CONTENTS
|
Rainforests Tropical Fish Madagascar Pictures Kids' Site Languages |
About Contact Archives Submissions Newsletter Contribute |
SUPPORT
You can help support mongabay.com by becoming a contributor to keep this site up and running. Thank you for your continued interest in the site.
Help support mongabay.com! Use the link below to buy from Amazon.com!
T-SHIRTS
Madagascar Wildlife
Save Madagascar
Sucking on this frog
may make you insane
In Madagascar there are
lemurs that dance
Don't fall asleep
the sloths will
eat you <
Canvas shopping bags
Some Blogs:
How to Save the World
Bottleworld
Earth-Info.Net
NewScientist Blog
Gristmill
Journal Watch
Celsias
Cleantech Blog
EcoGeek
EcoSherpa
Earth Blog
GreenOptions
Lime
Plenty Magazine
How the World Works
ScienceBlogs
Sierra Club Compass
The Oil Drum
Treehugger
Triple Pundit
WorldChanging
TOPICS
Africa
Agriculture
Alternative Energy
Amazon
Amphibian Crisis
Amphibians
Animal Behavior
Antarctica
Asia
Australia
Automobiles
Biodiversity
Bioenergy
Biofuels
Biomimicry
Birds
Borneo
Brazil
Bushmeat
California
Carbon Dioxide
Carbon Finance
Carbon Sequestration
Cellulosic Ethanol
China
Climate Change
Congo
Conservation
Coral Reefs
Deforestation
Ecological Services
Endangered Species
Energy
Environment
Environmental Law
Environmental Politics
Ethanol
Extinction
Fires
Fishing
Forests
Fossil Fuels
Green Business
Green Design
Green Energy
Greenland-Arctic
Happy-Upbeat Environmental
Hurricanes
Illegal Logging
India
Indigenous People
Indonesia
Interviews
Invasive Species
Lemurs
Logging
Madagascar
Mammals
Monkeys
New Guinea
Ocean Acidification
Oceans
Oil
Olpc
Orangutans
Palm Oil
Plants
Politics
Pollution
Population
Poverty Alleviation
Primates
Remote Sensing
Renewable Energy
Reptiles
Saving Rainforests
Sea Ice
Sea Levels
Sea Turtles
Sharks
Solar Power
Species Discovery
Strange
Technology
United States
Water
Whales
Wildlife
more
|
About | Privacy Copyright Rhett Butler 2009 |
